IHC/IF accessory reagents

IHC/IF accessory reagents

Descrizione	Azione
HSP70, a member of the heat shock protein family, is associated with cell division, apoptosis, and tumorigenesis. Studies have found that the expression of HSP70 may be related to the occurrence, development and prognosis of tumors. HSP70 antibodies also directly inhibit apoptosis and have been shown to be involved in the protective effects against heat stress and cytotoxic drugs. HSP70 is upregulated in HCC and is often used in HCC studies together with Glypican-3. HSP70 Monoclonal Antibody Codice: PA7169_3ml Confezionamento: 3ml	Dettagli
HSP70, a member of the heat shock protein family, is associated with cell division, apoptosis, and tumorigenesis. Studies have found that the expression of HSP70 may be related to the occurrence, development and prognosis of tumors. HSP70 antibodies also directly inhibit apoptosis and have been shown to be involved in the protective effects against heat stress and cytotoxic drugs. HSP70 is upregulated in HCC and is often used in HCC studies together with Glypican-3. HSP70 Monoclonal Antibody Codice: PA7169_6mL Confezionamento: 6mL	Dettagli
HSP70, a member of the heat shock protein family, is associated with cell division, apoptosis, and tumorigenesis. Studies have found that the expression of HSP70 may be related to the occurrence, development and prognosis of tumors. HSP70 antibodies also directly inhibit apoptosis and have been shown to be involved in the protective effects against heat stress and cytotoxic drugs. HSP70 is upregulated in HCC and is often used in HCC studies together with Glypican-3. HSP70 Monoclonal Antibody Codice: PA7169_1.5ml Confezionamento: 1.5ml	Dettagli
The IDH1 gene is located at 2q33 and encodes isocitrate dehydrogenase 1. Heterozygous point mutations at codon 132 of IDH1 frequently occur in WHO grade Ⅱ and Ⅲ gliomas. IDH1 gene mutation is somatic cell specific and only occurs in some subtypes of gliomas, which can be used as a basis for glioma subtyping. Heterozygous IDH1 mutation at position 132 occurs in more than 80% of low-grade gliomas, including astrocytoma, oligodendroglioma, oligodendroastrocytoma and secondary glioblastomas. Further studies have shown that the prognosis of IDH1 mutation is significantly better than that of wild type. Therefore, the identification of IDH1 gene mutation is an important reference index for pathological diagnosis and prognosis evaluation. IDH-1 Monoclonal Antibody Codice: PA7185_1.5ml Confezionamento: 1.5ml	Dettagli
The IDH1 gene is located at 2q33 and encodes isocitrate dehydrogenase 1. Heterozygous point mutations at codon 132 of IDH1 frequently occur in WHO grade Ⅱ and Ⅲ gliomas. IDH1 gene mutation is somatic cell specific and only occurs in some subtypes of gliomas, which can be used as a basis for glioma subtyping. Heterozygous IDH1 mutation at position 132 occurs in more than 80% of low-grade gliomas, including astrocytoma, oligodendroglioma, oligodendroastrocytoma and secondary glioblastomas. Further studies have shown that the prognosis of IDH1 mutation is significantly better than that of wild type. Therefore, the identification of IDH1 gene mutation is an important reference index for pathological diagnosis and prognosis evaluation. IDH-1 Monoclonal Antibody Codice: PA7185_6mL Confezionamento: 6mL	Dettagli
The IDH1 gene is located at 2q33 and encodes isocitrate dehydrogenase 1. Heterozygous point mutations at codon 132 of IDH1 frequently occur in WHO grade Ⅱ and Ⅲ gliomas. IDH1 gene mutation is somatic cell specific and only occurs in some subtypes of gliomas, which can be used as a basis for glioma subtyping. Heterozygous IDH1 mutation at position 132 occurs in more than 80% of low-grade gliomas, including astrocytoma, oligodendroglioma, oligodendroastrocytoma and secondary glioblastomas. Further studies have shown that the prognosis of IDH1 mutation is significantly better than that of wild type. Therefore, the identification of IDH1 gene mutation is an important reference index for pathological diagnosis and prognosis evaluation. IDH-1 Monoclonal Antibody Codice: PA7185_3ml Confezionamento: 3ml	Dettagli
The IDH1 gene is located at 2q33 and encodes isocitrate dehydrogenase 1. Heterozygous point mutations at codon 132 of IDH1 frequently occur in WHO grade Ⅱ and Ⅲ gliomas. IDH1 gene mutation is somatic cell specific and only occurs in some subtypes of gliomas, which can be used as a basis for glioma subtyping. Heterozygous IDH1 mutation at position 132 occurs in more than 80% of low-grade gliomas, including astrocytoma, oligodendroglioma, oligodendroastrocytoma and secondary glioblastomas. Further studies have shown that the prognosis of IDH1 mutation is significantly better than that of wild type. Therefore, the identification of IDH1 gene mutation is an important reference index for pathological diagnosis and prognosis evaluation. IDH-1 Monoclonal Antibody Codice: ELAB6945-R_0.2ml Confezionamento: 0.2ml	Dettagli
The IDH1 gene is located at 2q33 and encodes isocitrate dehydrogenase 1. Heterozygous point mutations at codon 132 of IDH1 frequently occur in WHO grade Ⅱ and Ⅲ gliomas. IDH1 gene mutation is somatic cell specific and only occurs in some subtypes of gliomas, which can be used as a basis for glioma subtyping. Heterozygous IDH1 mutation at position 132 occurs in more than 80% of low-grade gliomas, including astrocytoma, oligodendroglioma, oligodendroastrocytoma and secondary glioblastomas. Further studies have shown that the prognosis of IDH1 mutation is significantly better than that of wild type. Therefore, the identification of IDH1 gene mutation is an important reference index for pathological diagnosis and prognosis evaluation. IDH-1 Monoclonal Antibody Codice: ELAB6945-R_0.1ml Confezionamento: 0.1ml	Dettagli
The IDH1 gene is located at 2q33 and encodes isocitrate dehydrogenase 1. Heterozygous point mutations at codon 132 of IDH1 frequently occur in WHO grade Ⅱ and Ⅲ gliomas. IDH1 gene mutation is somatic cell specific and only occurs in some subtypes of gliomas, which can be used as a basis for glioma subtyping. Heterozygous IDH1 mutation at position 132 occurs in more than 80% of low-grade gliomas, including astrocytoma, oligodendroglioma, oligodendroastrocytoma and secondary glioblastomas. Further studies have shown that the prognosis of IDH1 mutation is significantly better than that of wild type. Therefore, the identification of IDH1 gene mutation is an important reference index for pathological diagnosis and prognosis evaluation. IDH-1 Monoclonal Antibody Codice: ELAB6945-R_1mL Confezionamento: 1mL	Dettagli
Immunoglobulin A (IgA) reacts with the A-chain of immunoglobulin IgA, an antibody that plays a key role in mucosal immune function. It has a certain auxiliary significance in the differential diagnosis of plasmacytoma and lymphoplasmacytic lymphoma, and can also be used for the functional classification of glomerulonephritis. IgA Monoclonal Antibody Codice: ELAB6964-R_0.2ml Confezionamento: 0.2ml	Dettagli
Immunoglobulin A (IgA) reacts with the A-chain of immunoglobulin IgA, an antibody that plays a key role in mucosal immune function. It has a certain auxiliary significance in the differential diagnosis of plasmacytoma and lymphoplasmacytic lymphoma, and can also be used for the functional classification of glomerulonephritis. IgA Monoclonal Antibody Codice: ELAB6964-R_0.1ml Confezionamento: 0.1ml	Dettagli
Immunoglobulin A (IgA) reacts with the A-chain of immunoglobulin IgA, an antibody that plays a key role in mucosal immune function. It has a certain auxiliary significance in the differential diagnosis of plasmacytoma and lymphoplasmacytic lymphoma, and can also be used for the functional classification of glomerulonephritis. IgA Monoclonal Antibody Codice: ELAB6964-R_1mL Confezionamento: 1mL	Dettagli

1…63 64 656667 68 69…114

Marca

Confezionamento

Conservazione

Specie target

Host

Clonalità

Clone

Coniugazione

Tipo di saggio

Data di scadenza

Applicazione

Reset

2025 TEMA Ricerca - All Rights Reserved.